购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
顶部生物活性储存和溶解信息计算器

(±)10(11)-EpDPA

Rating icon 还可以
(±)10(11)-EpDPA
产品编号 T35493Cas号 895127-65-8

Cytochrome P450 metabolism of polyunsaturated fatty acids produces numerous bioactive epoxide regioisomers. (±)10(11)-EpDPA is a docosahexaenoic acid epoxygenase metabolite, derived via epoxidation of the 10,11-double bond of DHA. It has been detected in rat brain and spinal cord, as well as human serum, and acts as a substrate for soluble epoxide hydrolase with a Km value of 5.1 μM. (±)10(11)-EpDPA and other epoxy metabolites of DHA are reported to demonstrate antihyperalgesic activity in inflammatory and neuropathic pain models and to potently inhibit angiogenesis and tumor growth in in vitro assays.

(±)10(11)-EpDPA
其他形式的 “(±)10(11)-EpDPA”:

(±)10(11)-EpDPA

Rating icon 还可以
(±)10(11)-EpDPA
产品编号 T35493Cas号 895127-65-8

Cytochrome P450 metabolism of polyunsaturated fatty acids produces numerous bioactive epoxide regioisomers. (±)10(11)-EpDPA is a docosahexaenoic acid epoxygenase metabolite, derived via epoxidation of the 10,11-double bond of DHA. It has been detected in rat brain and spinal cord, as well as human serum, and acts as a substrate for soluble epoxide hydrolase with a Km value of 5.1 μM. (±)10(11)-EpDPA and other epoxy metabolites of DHA are reported to demonstrate antihyperalgesic activity in inflammatory and neuropathic pain models and to potently inhibit angiogenesis and tumor growth in in vitro assays.

规格价格库存数量
25 μg
待估
35日内发货
50 μg
待估
35日内发货
100 μg
待估
35日内发货
500 μg
待估
35日内发货
大包装 & 定制
TargetMol 的所有产品仅用作科学研究或药证申报，不能被用于人体，我们不向个人提供产品和服务。请您遵守承诺用途，不得违反法律法规规定用于任何其他用途。
实验操作小课堂
常见问题解答
查看更多

(±)10(11)-EpDPA 相关产品

联系我们获取更多批次信息
资源下载
产品操作手册

产品介绍

生物活性
产品描述
Cytochrome P450 metabolism of polyunsaturated fatty acids produces numerous bioactive epoxide regioisomers. (±)10(11)-EpDPA is a docosahexaenoic acid epoxygenase metabolite, derived via epoxidation of the 10,11-double bond of DHA. It has been detected in rat brain and spinal cord, as well as human serum, and acts as a substrate for soluble epoxide hydrolase with a Km value of 5.1 μM. (±)10(11)-EpDPA and other epoxy metabolites of DHA are reported to demonstrate antihyperalgesic activity in inflammatory and neuropathic pain models and to potently inhibit angiogenesis and tumor growth in in vitro assays.
化学信息
分子量344.495
分子式C22H32O3
CAS No.895127-65-8
储存&溶解度
存储Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
溶解度信息
Ethanol: 50 mg/mL (145.14 mM), Sonication is recommended.
DMF: 25 mg/mL (72.57 mM), Sonication is recommended.
DMSO: 20 mg/mL (58.06 mM), Sonication is recommended.
Ethanol:PBS(pH 7.2) (1:1): 0.5 mg/mL (1.45 mM), Sonication is recommended.
溶液配制表
DMSO/DMF/Ethanol
1mg5mg10mg50mg
5 mM0.5806 mL2.9028 mL5.8056 mL29.0280 mL
10 mM0.2903 mL1.4514 mL2.9028 mL14.5140 mL
20 mM0.1451 mL0.7257 mL1.4514 mL7.2570 mL
50 mM0.0581 mL0.2903 mL0.5806 mL2.9028 mL

计算器

  • 摩尔浓度 计算器
  • 稀释 计算器
  • 配液 计算器
  • 分子量 计算器

体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算，可以得到母液配置方法和体内配方的制备方法：
TargetMol | Animal experiments比如您的给药剂量是 10 mg/kg ，每只动物体重 20 g ，给药体积 100 μL ， TargetMol | Animal experiments 一共给药动物 10 只 ，您使用的配方为 5% TargetMol | reagent DMSO+ 30%PEG300+ 5%Tween 80 + 60%Saline/PBS/ddH2O， 那么您的工作液浓度为 2 mg/mL 。
母液配置方法: 2 mg 药物溶于 50 μLDMSOTargetMol | reagent （ 母液浓度为 40 mg/mL ）, 如您需要配置的浓度超过该产品的溶解度，请先与我们联系。
体内配方的制备方法: 取 50μLDMSOTargetMol | reagent 母液，添加 300 μLPEG300TargetMol | reagent 混匀澄清，再加 50μLTween 80, 混匀澄清，再加 600μLSaline/PBS/ddH2OTargetMol | reagent 混匀澄清

以上为“体内实验配液计算器”的使用方法举例，并不是具体某个化合物的推荐配制方式，请根据您的实验动物和给药方式选择适当的溶解方案。

1 请输入动物实验的基本信息
mg/kg
g
μL
2 请输入动物体内配方组成，不同的产品配方组成不同，如有配方需求，可先联系我们提供正确的体内配方。
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

剂量转换

对于不同动物的给药剂量换算，您也可以参考 更多

关键词

(±)10(11)EpDPA(±)10(11) EpDPA10(11)-EpDPA

评论列表

4个月前
5.0
Rating icon 很棒

评论内容

233
Related Tags: buy (±)10(11)-EpDPA | purchase (±)10(11)-EpDPA | (±)10(11)-EpDPA cost | order (±)10(11)-EpDPA | (±)10(11)-EpDPA chemical structure | (±)10(11)-EpDPA formula | (±)10(11)-EpDPA molecular weight